Safety and efficacy of the BNT162b2 mRNA COVID-19 vaccine during Ixekizumab treatment for hidradenitis suppurativa

Detalles Bibliográficos
Autores principales: Iannone, Michela, Janowska, Agata, Tonini, Giulia, Davini, Giulia, Dini, Valentina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Inc. 2021
Materias:
COVID-19: Important Updates and Developments
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8131181/
https://www.ncbi.nlm.nih.gov/pubmed/34809775
http://dx.doi.org/10.1016/j.clindermatol.2021.05.026

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8131181/
https://www.ncbi.nlm.nih.gov/pubmed/34809775
http://dx.doi.org/10.1016/j.clindermatol.2021.05.026

Ejemplares similares